2025
SJR Q1
JCR Q2 · 2,9
7 matched articles
SCIE
Journal detail
Cytometry Part B - Clinical Cytometry
- Publisher
- Wiley-Liss Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1552494915524957
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,032
- Quartile Q1
- H-Index 74
- Cites/doc 2,64
- Docs (3y) 151
- Cites (3y) 340
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,9
- 5Y JIF 3
- JCI 1,12
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cell Biology Q2
- Histology Q1
- Pathology and Forensic Medicine Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Medical Laboratory Technology | Pathology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,032 | 2,9 | 3 | 1,12 | Q1 | 74 |
| 2024 | Q1 | Q2 | 0,937 | 2,7 | 2,7 | 1,09 | Q1 | 73 |
| 2023 | Q1 | Q2 | 0,899 | 2,3 | 2,5 | 1,04 | Q2 | 73 |
| 2022 | Q1 | Q2 | 0,954 | 3,4 | 2,9 | 0,99 | Q2 | 73 |
| 2021 | Q1 | Q2 | 0,913 | 3,2 | 3,1 | 0,97 | Q2 | 73 |
| 2020 | Q2 | Q2 | 0,646 | 3,1 | 2,8 | 1,04 | Q2 | 73 |
| 2019 | Q1 | Q3 | 0,912 | 2,1 | 2,2 | 1,14 | Q1 | 73 |
| 2018 | — | Q1 | — | 2,9 | 2,7 | 1,1 | Q1 | — |
| 2017 | Q1 | Q2 | 1,042 | 2,8 | 2,5 | 1,07 | Q2 | 73 |
| 2016 | Q1 | Q2 | 0,849 | 2,5 | 2,2 | — | — | 73 |
| 2015 | Q2 | Q1 | 0,846 | 2,8 | 2,3 | — | — | 73 |
| 2014 | Q2 | Q2 | 0,758 | 2,4 | 2,3 | — | — | 73 |
| 2013 | Q1 | Q2 | 1,138 | 2,3 | 2,4 | — | — | 73 |
| 2012 | Q1 | Q2 | 1,09 | 2,2 | 2,3 | — | — | 73 |
| 2011 | Q1 | Q1 | 1,073 | 2,5 | 2,3 | — | — | 73 |
| 2010 | Q2 | Q2 | 0,785 | 2 | 2 | — | — | 73 |
| 2009 | — | Q2 | — | 1,7 | 1,9 | — | — | — |
| 2008 | — | Q2 | — | 2,6 | 2,5 | — | — | — |
| 2007 | — | Q2 | — | 2,3 | 2,1 | — | — | — |
| 2006 | — | Q2 | — | 2,1 | — | — | — | — |
| 2005 | — | Q3 | — | 1,7 | — | — | — | — |
| 2004 | — | Q3 | — | 1,4 | — | — | — | — |
| 2003 | — | — | — | — | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | Q2 | 12/33 |
| 2025 | PATHOLOGY | SCIE | Q2 | Q1 | 30/89 |
| 2024 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | Q2 | 13/33 |
| 2024 | PATHOLOGY | SCIE | Q2 | Q1 | 33/90 |
| 2023 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | Q2 | 16/31 |
| 2023 | PATHOLOGY | SCIE | Q2 | Q2 | 42/88 |
| 2022 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | Q2 | 9/29 |
| 2022 | PATHOLOGY | SCIE | Q2 | Q2 | 28/76 |
| 2021 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | Q2 | 12/29 |
| 2021 | PATHOLOGY | SCIE | Q2 | Q2 | 38/77 |
| 2020 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | Q2 | 14/29 |
| 2020 | PATHOLOGY | SCIE | Q2 | Q2 | 37/77 |
| 2019 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | Q1 | 16/29 |
| 2019 | PATHOLOGY | SCIE | Q3 | Q1 | 41/78 |
| 2018 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q1 | Q1 | 7/29 |
| 2018 | PATHOLOGY | SCIE | Q2 | Q1 | 23/76 |
| 2017 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | Q2 | 10/30 |
| 2017 | PATHOLOGY | SCIE | Q2 | Q2 | 24/79 |
| 2016 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | — | 10/30 |
| 2016 | PATHOLOGY | SCIE | Q2 | — | 24/79 |
| 2015 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q1 | — | 6/30 |
| 2015 | PATHOLOGY | SCIE | Q2 | — | 21/79 |
| 2014 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | — | 10/30 |
| 2014 | PATHOLOGY | SCIE | Q2 | — | 29/76 |
| 2013 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | — | 9/31 |
| 2013 | PATHOLOGY | SCIE | Q2 | — | 31/76 |
| 2012 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | — | 10/32 |
| 2012 | PATHOLOGY | SCIE | Q2 | — | 32/77 |
| 2011 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q1 | — | 7/32 |
| 2011 | PATHOLOGY | SCIE | Q2 | — | 27/79 |
| 2010 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | — | 12/31 |
| 2010 | PATHOLOGY | SCIE | Q2 | — | 37/76 |
| 2009 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | — | 11/29 |
| 2009 | PATHOLOGY | SCIE | Q3 | — | 38/71 |
| 2008 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | — | 7/27 |
| 2008 | PATHOLOGY | SCIE | Q2 | — | 23/69 |
| 2007 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | — | 8/26 |
| 2007 | PATHOLOGY | SCIE | Q2 | — | 22/66 |
| 2006 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | — | 7/25 |
| 2006 | PATHOLOGY | SCIE | Q2 | — | 27/64 |
| 2005 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q3 | — | 32/53 |
| 2005 | CELL BIOLOGY | SCIE | Q3 | — | 109/153 |
| 2004 | BIOCHEMICAL RESEARCH METHODS | SCIE | Q3 | — | 32/51 |
| 2004 | CELL BIOLOGY | SCIE | Q3 | — | 115/155 |
| 2003 | BIOCHEMICAL RESEARCH METHODS | SCIE | — | — | — |
| 2003 | CELL BIOLOGY | SCIE | — | — | — |